Similar articles

• Allogeneic versus autologous bone marrow transplantation (BMT) versus intensive consolidation in acute myelogenous leukemia (AML) in first remission. An EORTC-Gimema phase III trial (AML8 A). The EORTC Leukemia Cooperative Group and the GIMEMA Group.

  Zittoun R, Mandelli F, Willemze R, de Witte T, Tura S, Ferrini PR, Stryckmans P, Gattringer C, Petti MC, Solbu G, et al. Zittoun R, et al. Leukemia. 1992;6 Suppl 2:114-5. Leukemia. 1992. PMID: 1578909 Clinical Trial. No abstract available.
• Autologous bone marrow transplantation in first remission AML--its relative value.

  de Gast GC, Zwaan FE, Hagenbeek T, Verdonck LF, Löwenberg B. de Gast GC, et al. Bone Marrow Transplant. 1990 Jul;6 Suppl 1:52-4. Bone Marrow Transplant. 1990. PMID: 2202468 Review. No abstract available.
• Methodology of evaluation in EORTC trials including BMT in acute myelogenous leukemia (AML) in first complete remission (CR). EORTC Leukemia Cooperative Group (LCG) and GIMEMA.

  Suciu S, Solbu G, Zittoun R, Hayat M, Willemze R, de Witte T, Mandelli F. Suciu S, et al. Bone Marrow Transplant. 1991;7 Suppl 2:34. Bone Marrow Transplant. 1991. PMID: 1878707 Clinical Trial. No abstract available.
• Post remission treatment in acute myelogenous leukaemia in first remission. The EORTC experience. EORTC Leukemia Cooperative Group.

  Willemze R, Zittoun R, Mandelli F, Tura S, de Witte T, Stryckmans P, Suciu S, Solbu G. Willemze R, et al. Bone Marrow Transplant. 1989 Dec;4 Suppl 3:72. Bone Marrow Transplant. 1989. PMID: 2697406 Clinical Trial. No abstract available.
• Acute myeloid leukemia and the position of autologous stem cell transplantation.

  Breems DA, Löwenberg B. Breems DA, et al. Semin Hematol. 2007 Oct;44(4):259-66. doi: 10.1053/j.seminhematol.2007.08.002. Semin Hematol. 2007. PMID: 17961725 Review.